Members of the Kentucky Senate debated drug prices Friday in the context of rural hospitals providing services to low-income citizens. It became a philosophical discussion about financial impacts for individuals and the healthcare system.
The bill seeks to prohibit drug manufacturers from scaling back sizeable discounts to providers who serve a disproportionate number of Medicaid or self-pay patients. Responding to comments about cost-shifting, GOP Bill Sponsor Stephen Meredith said it’s a vote for Main Street or Wall Street.
